| 名称 | KRAS G12C-Y96S/BaF3细胞株 |
| 型号 | CBP73376 |
| 报价 |  |
| 特点 | KRAS G12C-Y96S/BaF3 |
产品搜索
相关文章
联系我们
联系人：蒋经理
电话：4008750250
号码：
手机：18066071954
地址：南京市栖霞区纬地路9号
Email： zhangxiangwen@cobioer.com
电话：4008750250
号码：
手机：18066071954
地址：南京市栖霞区纬地路9号
Email： zhangxiangwen@cobioer.com
产品展示 / PRODUCTS
药靶细胞株 > kinase激酶细胞株 > CBP73376KRAS G12C-Y96S/BaF3细胞株
- 详细内容
| CBP73376 | |
| I. Introduction | |
Cell Line Name： | KRAS G12C-Y96S/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS+2ug/ml puromycin |
Mycoplasma Status: | Negative |
| II.Background | |
KRAS, KRAS proto-oncogene, GTPase, is a member of the small GTPase superfamily and a key regulator of the MAPK, PI3K/AKT/mTOR pathways (PMID: 23622131). KRAS mutations are identified in a wide range of cancers (PMID: 28666118). | |
| III. Representative Data | |
1. Anti-proliferation assay
Figure 1. CTG Proliferation Assay of KRAS G12C/Y96S BaF3 Cells (C2). | |
